InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Heinen Mark, Executive. Director active across 1 company, notably Better Therapeutics, Inc.. Aggregated, 7 filings have been published. Split: 5 buys · 0 sell. Total volume traded: €25k. Activity tracked since 13 December 2021. The latest transaction was disclosed on 24 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
2,280.605 shares@ US$1.753969.75% mcap15.3% of flowCommon StockSEC:0000899243-22-024391:0
Ideal exit: 21 Mar 2023 (T+270)
5,000 shares@ US$1.5629.5% of flowCommon StockSEC:0000899243-22-021998:0
Ideal exit: 7 Mar 2023 (T+270)
5,000 shares@ US$1.9835.9% of flowCommon StockSEC:0000899243-22-013344:0
Ideal exit: 26 Dec 2022 (T+270)
500 shares@ US$5.4544.19% mcap100.0% of flowCommon StockSEC:0000899243-21-048374
Ideal exit: 9 Sept 2022 (T+270)
500 shares@ US$5.4544.19% mcap9.7% of flowCommon StockSEC:0000899243-21-048374:0
Ideal exit: 9 Sept 2022 (T+270)
6,667 sharesCommon StockSEC:0000899243-21-042247:0
6,667 sharesCommon StockSEC:0000899243-21-042247
7 of 7 declarations
About Heinen Mark
Heinen Mark is an executive at Better Therapeutics, Inc., a health technology company. He contributes to the strategic and operational direction of the company, aiming to develop innovative solutions.
